Welireg generated $139 million in sales during 2024’s third quarter and is the only approved HIF-2α inhibitor in the U.S. Merck’s application in PPGL is based on objective response rate and ...

The FDA has accepted Merck's (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known as belzutifan, for the treatment of a rare type of adrenal gland ...

Acceptance based on objective response rate data from the Phase 2 LITESPARK-015 trial evaluating WELIREG in certain patients with advanced PPGL If approved, WELIREG would be the only available therapy ...

It’s been a few years since Google took the first steps towards what has now become its most ubiquitous and consistent feature across multiple devices: the smart home panel. What started out as ...

The fourth-generation panel, capable of hitting 4,000 nits, is already in some of 2025’s most anticipated TVs including the LG G5 and Panasonic’s Z95B. The fourth-generation panel, capable of ...

or metastatic pheochromocytoma and paraganglioma (PPGL). The sNDA is based on objective response rate (ORR) and duration of response (DOR) data from the Phase II LITESPARK-015 trial, which will be ...

Investment firm Ancora Holdings Group has taken a stake in United States Steel and is looking to oust leadership at the ...

Democratic former U.S. Rep. Abigail Spanberger and Republican Virginia Lt. Gov. Winsome Earle-Sears are picking up steam in ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...